CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option

卷:12

Review

关键词: REGULATORY T-CELLS;    ACUTE LYMPHOBLASTIC-LEUKEMIA;    RHEUMATOID-ARTHRITIS;    B-CELLS;    PEMPHIGUS-VULGARIS;    CHIMERIC RECEPTORS;    CANCER REGRESSION;    ADOPTIVE TRANSFER;    TARGETED THERAPY;    IN-VITRO;   

DOI  :  10.3390/cells12111534

来源: SCIE

【 摘 要 】

The pervasive application of chimeric antigen receptor (CAR)-based cellular therapies in the treatment of oncological diseases has long been recognized. However, CAR T cells can target and eliminate autoreactive cells in autoimmune and immune-mediated diseases. By doing so, they can contribute to an effective and relatively long-lasting remission. In turn, CAR Treg interventions may have a highly effective and durable immunomodulatory effect via a direct or bystander effect, which may have a positive impact on the course and prognosis of autoimmune diseases. CAR-based cellular techniques have a complex theoretical foundation and are difficult to implement in practice, but they have a remarkable capacity to suppress the destructive functions of the immune system. This article provides an overview of the numerous CAR-based therapeutic options developed for the treatment of immune-mediated and autoimmune diseases. We believe that well-designed, rigorously tested cellular therapies could provide a promising new personalized treatment strategy for a significant number of patients with immune-mediated disorders.